Inari Medical Balance Sheet Health

Financial Health criteria checks 6/6

Inari Medical has a total shareholder equity of $447.2M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $661.8M and $214.5M respectively.

Key information

0%

Debt to equity ratio

US$0

Debt

Interest coverage ration/a
CashUS$101.30m
EquityUS$447.23m
Total liabilitiesUS$214.55m
Total assetsUS$661.78m

Recent financial health updates

Recent updates

Is Inari Medical, Inc. (NASDAQ:NARI) Trading At A 29% Discount?

May 02
Is Inari Medical, Inc. (NASDAQ:NARI) Trading At A 29% Discount?

Inari Medical: Buy On Growing TAM

Mar 27

Why We're Not Concerned Yet About Inari Medical, Inc.'s (NASDAQ:NARI) 25% Share Price Plunge

Mar 08
Why We're Not Concerned Yet About Inari Medical, Inc.'s (NASDAQ:NARI) 25% Share Price Plunge

Is Now The Time To Look At Buying Inari Medical, Inc. (NASDAQ:NARI)?

Dec 14
Is Now The Time To Look At Buying Inari Medical, Inc. (NASDAQ:NARI)?

A Look At The Fair Value Of Inari Medical, Inc. (NASDAQ:NARI)

Oct 23
A Look At The Fair Value Of Inari Medical, Inc. (NASDAQ:NARI)

Inari Medical (NASDAQ:NARI) Is In A Strong Position To Grow Its Business

Sep 18
Inari Medical (NASDAQ:NARI) Is In A Strong Position To Grow Its Business

Is Inari Medical, Inc. (NASDAQ:NARI) Potentially Undervalued?

Aug 14
Is Inari Medical, Inc. (NASDAQ:NARI) Potentially Undervalued?

Inari Medical, Inc. (NASDAQ:NARI) Shares Could Be 23% Above Their Intrinsic Value Estimate

Jul 25
Inari Medical, Inc. (NASDAQ:NARI) Shares Could Be 23% Above Their Intrinsic Value Estimate

We Think Inari Medical (NASDAQ:NARI) Can Afford To Drive Business Growth

Jun 18
We Think Inari Medical (NASDAQ:NARI) Can Afford To Drive Business Growth

Inari Medical, Inc.'s (NASDAQ:NARI) Price In Tune With Revenues

Apr 17
Inari Medical, Inc.'s (NASDAQ:NARI) Price In Tune With Revenues

Is Inari Medical, Inc. (NASDAQ:NARI) Potentially Undervalued?

Dec 07
Is Inari Medical, Inc. (NASDAQ:NARI) Potentially Undervalued?

Study assessing Inari Medical's blood clot removal system shows low rate of adverse events

Sep 19

Inari Medical: Growth Set To Reaccelerate In The Back Half Of The Year

Sep 07

Inari Medical stock falls as Q2 sees net loss; COO to helm company next year

Aug 03

Inari Medical: Fundamentals Soft, Technicals Supportive Of Near-Term Upside Capture

Jul 22

Financial Position Analysis

Short Term Liabilities: NARI's short term assets ($233.3M) exceed its short term liabilities ($86.0M).

Long Term Liabilities: NARI's short term assets ($233.3M) exceed its long term liabilities ($128.5M).


Debt to Equity History and Analysis

Debt Level: NARI is debt free.

Reducing Debt: NARI has no debt compared to 5 years ago when its debt to equity ratio was 80.1%.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: Whilst unprofitable NARI has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.

Forecast Cash Runway: NARI is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 32.1% per year.


Discover healthy companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.